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Abstract: Atomic force microscopy (AFM), a unique tool to investigate drug treatment of
cancer cells, was used to analyze the anti-neoplastic activity of adriamycin by comparing
DNA structures of non-treated and adriamycin-treated Ehrlich tumor cells. The non-treated
cells exhibited a highly branched intact chromatin structure, related to the intensive DNA
replication in cancer cells. Images from adriamycin-treated tumor cells showed that the
DNAchains were broken and the chromatin structure had been destroyed. Possible explana-
tions for these effects of adriamycin are considered: breakage of hydrogen bonding, oxida-
tion and intercalation effects, as well as the poisoning of topoisomerase enzyme. DNA
fractal and multifractal analyses, performed in order to evaluate the degree of bond scission,
showed that the treated DNA had become more fractal compared to non-treated DNA.
Keywords: adriamycin, Ehrlich tumor cells, atomic force microscopy, topoisomerase, fractal
and multifractal analysis.
INTRODUCTION
Adriamycin (ADR), the first anthracycline drug, has been used in clinical practice
since the 1960’s and still remains the most widely used anticancer therapeutic with a wide
spectrum of anti-neoplastic action.1 However, its mode of action is not yet fully under-
stood, although it is known that it intercalates strongly with the DNAdouble helix, mainly
at CG-GC steps, the amino sugar being determinant for intercalation to occur.2 In addition,
ADR interferes with the DNA regulation machinery in several ways, thus promoting the
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generation of reactive oxygen species, which ultimately cause oxidative damage to
biomolecules.3,4 In fact, a high level of 8-oxoguanine (a main biomarker of DNA oxida-
tion) was detected in cancerous cells treated in vitro with adriamycin,5 but it is not known
whether or not ADR, after intercalation, directly oxidizes DNA in vivo.
In addition, ADR is referred to as a “topoisomerase II poison”.6–8 Eukaryotic type
II topoisomerase is a multifunctional nuclear enzyme responsible for relieving DNA
from the topological constraints by cleaving both DNAstrands, which facilitates various
cellular processes, such as transcription, replication, sister chromatid disjunction and
chromosome segregation.9 “Topoisomerase II poisons” significantly increase the levels
of enzyme-mediated DNA cleavage, thus leading to the topoisomerase II inactiva-
tion.6,10 It is believed that this is the most important mechanism of anthracyclines
cytotoxicity.1
Different electrochemical DNA-biosensors for the detection of DNA–drug inter-
actions and DNAoxidative damage have recently been investigated.11–13 Additionally
atomic force microscopy (AFM), a unique tool for the high-resolution characterization
of biological objects, can be used to explain interactions between DNA molecules and
different anti-neoplastic drugs.14,15 AFM enables the recognition and identification of
molecular interactions occurring during functional rearrangements in situ. The great
advantage of AFM compared to other microscopic methods is that high vacuum is no
longer required and samples can be analysed in their hydrated form, under liquid. An
atomically flat mica surface serves well as a support for biomolecules in AFM investi-
gations. However, the non-specific physical adsorption of biologically important
macromolecules (proteins and nucleic acid) to this hydrophilic surface may interfere
with the preservation of their native state.14
The aim of this work was to gain an understanding of the interactions between
adriamycin and DNA leading to ADR antitumor activity in malignant cells in vitro.
Atomic force microscopy was used to study this interaction in DNA samples extracted
from ADR-treated and untreated Ehrlich ascites tumor cells. Additionally, the AFM
images were analyzed using fractal (FG) and multifractal (MF) geometry in order to
determine the degree of DNA discontinuity caused by the drug treatment.
EXPERIMENTAL
Chemicals
Adriablastina (ADR), commercially available powder for injection, was from Pharmacia &
Upjohn S.p.A. (Milan, Italy). A working solution of ADR was prepared one hour before each series of
experiments. The final concentration of ADR was 10-7 M. RPMI 1640 culture medium was purchased
from GIBCO Brl (Life Technologies, Scotland), fetal calf serum (FCS) from NIVNS (Novi Sad, Serbia
and Montenegro) and antibiotics from ICN Galenika (Belgrade, Serbia and Montenegro). All other
chemicals used in the study were special grade commercial products or reagents of analytical grade.
Cell culture
Ehrlich ascites tumor cells were grown in the abdominal cavity of NMRI mice, age approximately
five–seven weeks. Ten days after inoculation, the cells were isolated by needle aspiration, washed in sa-
line, and the erythrocytes were removed with a lysing solution (Becton Dickinson).
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Approximately 5 – 7  106 cells were cultured in 10 ml of RPMI 1640 supplemented with 10 % of
fetal calf serum and antibiotics: 100 IU/ml of penicillin and 100 mg/ml of streptomycin. The cells were
treated with ADR (10-7 M) while control samples were treated with the corresponding volume of com-
plete medium. All samples were cultured for two hours at 37 ºC in a 100 % humidity atmosphere con-
taining 5 % of CO2. After treatment, the cells were pelleted (200  g / 10 min), washed once in 10 ml of
PBS (pH 7.2), resuspended in 1 ml of PBS, and counted in a hemocytometer. The cell density and per-
centage of viable cells were determined by the trypan blue dye exclusion test.16
Extraction and precipitation of DNA
DNAwas extracted from the ADR-treated and untreated Ehrlich ascites tumor cells using mixtures
of phenol, chloroform and isoamyl alcohol.17 Briefly: at least 2  106 / ml of viable cells were washed in
cold PBS by centrifugation (1000  g for 10 min) and lysed with cold lysis buffer (10 mM Tris-HCl, pH
7.4, 10 mM sodium chloride, 10 mM EDTA) for three minutes on ice with gentle vortexing. Sodium
dodecyl sulfate (SDS, 1 %) and proteinase K (200 g/ml) were added and the mixture was incubated
(1.45 h) at 50 ºC.
The fragmented DNA was extracted twice using phenol/chloroform/isoamyl alcohol (25:24:1
v/v/v). The DNA was precipitated with ethanol and high salt. The DNA pellet was washed once in 70 %
ethanol and stored at –20 ºC.
For the AFM analysis, the ethanol was poured off and the DNA was resuspended in Tris EDTA
(TE) buffer (pH 8.0) by gentle mixing.
AFM measurements
The measurements were carried out using a Nanoscope IIIa controller with a Multimode AFM
(Digital Instruments, Santa Barbara, CA). The DNA sample was dissolved in Tris buffer and placed in
drops on a Mg2+ - treated mica surface. After half an hour of adsorption, the sample was rinsed with Tris
buffer and dried. The investigation was carried out in the contact mode using a DI cantilever of 0.12 N/m
spring constant.
RESULTS AND DISCUSSION
As previously reported, DNA – adriamycin interaction at charged interfaces repre-
sents the in vivo situation much better than a solution of these two compounds themselves.
An electrochemical DNA-biosensor enabled the detection and a better understanding of
DNA/molecule/ion interactions, i.e., in situ adriamycin caused oxidative damage to
DNA.18 The DNA extracted from untreated Ehrlich tumor cells were adsorbed onto mica
(according to the described experimental procedure) and visualized by AFM.
The chromatin structure of untreated cells is shown in Fig. 1, which indicates a he-
lix form of “superstructure” above the basic DNA double helix.19 The basic DNA fi-
bers (3–4 nm) are packed with proteins into bigger fibers, i.e., a chromatin “superstruc-
ture” 30–40 nm wide. These numerical values correspond to the microscopically ob-
served parameters.
A larger scale AFM image is presented in Fig. 2 where proteins bound at the junc-
tions of the fibers can be identified.
An AFM image of DNA extracted from in vitro ADR-treated Ehrlich ascites tu-
mor cells is presented in Fig. 3. It can be clearly seen that the original structure has
been destroyed under adriamycin activity. The interaction of DNAwith adriamycin re-
sulted in broken chains of double helices, which is probably the main anti-neoplastic
effect of this drug.
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There are few possible explanations for the observed phenomenon of the degrada-
tion of native DNA.
The degradation can be caused by the destruction of hydrogen bonds as they are es-
sential components of the structure and function of biological molecules. These bonds
are very rigid and not easily broken and yet strong hydrogen bonds are rare in biological
structures. The strongest hydrogen bonds are so called salt bridges, NH...O=C in pro-
teins and P–OH...O=P bonds in nucleic acids.20 Molecules of water or any potent or-
ganic substance, such as the anthracycline antibiotic, adriamycin, can interrupt hydrogen
bonds and thus destroy them. Subsequently, this can lead to the induction of breaks in
DNA single and double strands and considerable death of tumor cells.18
A second possibility is the structural modification of DNA strands caused by interca-
lation of adriamycin molecules. This mode of ADR action is not yet fully understood, but
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Fig. 1. AFM image of chromatin structure isolated
from untreated Ehrlich ascites tumor cells. The mea-
surement was taken in the contact imaging mode un-
der ambient conditions.
Fig. 2. AFM image of DNA isolated from untreated
Ehrlich ascites tumor cells. The measurement was
taken in the contact imaging mode under ambient
conditions.
Fig. 3. AFM image of DNAisolated from Ehrlich
ascites tumor cells treated with adriamycin. The
measurement was taken in the contact imaging
mode under ambient conditions.
it may be through intercalation in the DNAdouble helix and interaction with CG-GC base
pairs.2 As was recently shown,21 the oxidation and reduction of adriamycin molecules in-
tercalated in double helix DNA is potential-dependent, causing contact between guanine
and adenine bases of DNA. It is assumed that the adriamycin amino sugar moiety plays a
very important role in this intercalation. The existence of irregular cyclic- or stellar-shaped
DNA, or random coil conformations in a treated sample (Fig. 2) indicate that native DNA
is degraded probably to double stranded fragments by both double strand scissions at one
locus and single strand breaks. This means that the result of this interaction is a specific as-
sociation of the two broken chains of the double helix. The possibility that adriamycin in-
tercalated to double helix DNA reacts specifically with the guanine moiety is known and
may lead to base pairing mismatch.
As a third possibility, it is believed that anthracycline drugs stabilize a covalent
topoisomerase II – DNA intermediate. This effect is achieved by forming a ternary
enzyme–poison–DNAcomplex in which both DNAstrands are broken and covalently
linked to enzyme subunits.22 This intermediate disables repair of broken strands and
the double helix breaks remain intact, as can be seen in Fig. 3. Topoisomerase II activ-
ity increases significantly during periods of rapid cell proliferation,23 which is the situ-
ation shown in Fig. 2 (intensive DNAreplication in Ehrlich ascites tumor cells). When
treated with adriamycin, native DNAis significantly degraded and the breakage points
probably correspond to activity of topoisomerase II.
The AFM images of untreated and ADR-treated DNA, shown in Figs. 2 and 3, were
also analyzed by the fractal geometry and multifractal spectrum approaches.24–28 It is
important to point out that fractal analysis in biology and medicine has already been suc-
cessfully used by several authors.29–32 Fractal and multifractal analyses were applied to
a part of the AFM image shown in Fig. 4. The two-dimensional grey-level signals were
converted to the corresponding one-dimensional (i.e., scanned) signals and fractal and
multifractal analyses applied. The fractal nature of the signal was checked by the value
of the Hurst index, H. It is known that processes having a value of the Hurst index be-
tween 0.5 and 1.0 exhibit self-similarity (repeated structure in all scales), i.e, these pro-
cesses have fractal behaviour. The Hurst index24,26 was determined by using the
periodogram method. The calculated values were Hcntrl=0.696 and Htreat=0.699 for
CONTROL (non-treated) and TREATED sample, respectively, indicating the fractal na-
ture of both samples. Although the fractal analysis enabled a number of non-regular phe-
nomena to be described, this method suffers from at least one drawback: it assumes
self-similarity but uses binary “yes-no” logic. For many phenomena, it is more appropri-
ate to use a scale of measures between limiting (max and min) values. In this case fractal
analysis can be extended to multifractal (MF) approach.24 The MF method assumes two
quantities are derived: the values of so-called Hölder exponents, , describing the local
regularity of signal points, and the value of the distribution of these coefficients – usually
known as the spectrum of , or the multifractal (MF) spectrum, f(), in short. The MF
spectrum gives the global description of the signal (or, more generally, of the phenome-
non under investigation). The so-called coarse Hölder exponent at point (x) is given by
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(x)(i) = [ln c(x) (i)]/[ln(i)],where c(x)(i) is the signal measure (or, the capacity)
25 de-
scribing some signal feature (for instance, the grey level of the image) acting on a mea-
sure domain, and i is the dimension of the surrounding across the observed point (the
measure domain). From this, the pointwise digital Hölder  exponent is determined as:
(x) = lim ( )( )
i
x
i
0
 = lim ln ( )
( )
i
x
c i i
0
[ ] / [ln( )]. Once the coefficients  have been found,
the distribution of these quantities, usually known to as the multifractal spectrum, f(),
may be derived, describing the global behaviour of the signal. Probably a simpler way
of deriving an MF spectrum is that based on the Hausdorff measure (or, Hausdorff di-
mension). This procedure first assumes that the whole range of  (min to max) be di-
vided into N subranges. Subsequently, the Hausdorff dimension is calculated for every
subrange, particularly. Usually, a uniform subdivision is assumed  = (max – min)/N.
If k denotes the k-th subrange, then its scope is k –  k + .
The so-called box-counting algorithm is the most often used method for the esti-
mation of the Hausdorff dimension.26 The  matrix is covered by a regular grid of
boxes. After covering with boxes, the number of non-empty boxes Ni (k) is counted.
A box is non-empty if at least one value from a given subrange k is found within it,
which means if k –  < (x) < k +  holds for at least one point (x) within the box.
Boxes of different sizes are recursively taken, and from a bilogarithmic diagram ln i  ln
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Fig. 4. Part of DNA images (extracted from Figs. 2 and 3), respectively denoted as CONTROL (not treated)
and TREATED, and their multifractal spectra.
Ni (k), the Hausdorff dimension k of a subrange is calculated by linear fitting: f(k) =
lim
i0
[ln Ni(k)/ln(1/i)]. A simplified version of this method, known as the histogram
method24,26 has been developed as a computer program HISTMF.28 This program
was used for determining the MF spectra of the AFM images, shown in the second row
of Fig. 4.
From the MF spectra, Fig. 4, it is evident that the DNA after treatment exhibits
more discontinuities since the spectrum becomes more right-sided, i.e., the main part
of the MF spectrum is to the right of its maximum.27 The obtained results clearly dem-
onstrate that fractal and multifractal analyses can be successfully applied for the evalu-
ation of drug efficiency in cancer research.
CONCLUSIONS
Adriamycin is one of the most important anti-neoplastic agents used widely in
clinical practice, especially in the treatment of human neoplasms. A number of impor-
tant biochemical effects have been described but the exact mode of adriamycin
antineoplastic action is not yet fully understood. Atomic force microscopy serves as a
unique tool in the investigation of drug treatment of cancer cells. Hence, this method
was used to analyze the anti-neoplastic activity of adriamycin by comparing DNA
structures extracted from ADR-treated and non-treated Ehrlich tumor cells. Non-tre-
ated DNA exhibited an intact chromatin structure, i.e., the chromatin had a highly
branched appearance, related to the intensive DNA replication in cancer cells.
Images of DNAextracted from Ehrlich ascites tumor cells treated with adriamycin in
vitro showed that the chromatin is destroyed under the effect of adriamycin and the chains
of the double helix are broken. Possible explanations for this morphological effect of
adriamycin activity are considered, such as the scission of hydrogen bonds, oxidation and
intercalation effects, as well as the poisoning of topoisomerase enzyme by adriamycin.
Fractal and multifractal analyses of the AFM images of the DNA samples were
performed in order to evaluate the degree of bond scission. Fractal analysis showed
that treated DNA becomes more fractal than non-treated DNA. Moreover, the multi-
fractal spectrum of an ADR-treated DNA sample, obtained by the histogram method,
indicates the existence of more discontinuities of the signal and of its derivative in the
image in comparison with that of the non-treated DNA. This type of analysis gives the
possibility of numerically evaluating drug efficiency, which will be one of the guide-
lines in our further research activities.
As can be seen, both analyses showed a significant difference in the morphology
of the chromatin of non-treated and adriamycin-treated cells. This combination of
AFM and fractal analysis enabled adriamycin anticancer activity to be better under-
stood and numerically evaluated and, thus, can be of great importance for the future
development of anticancer therapeutics.
DNA STRUCTURES 829
I Z V O D
AFM MIKROSKOPIJA DNA IZOLOVANE IZ ERLIHOVIH TUMORSKIH
]ELIJA TRETIRANIH I NETRETIRANIH ADRIAMICINOM
M. AVRAMOV IVI]
1
, S. D. PETROVI]
2,3
, E. KALMN6, T. MILOSAVQEVI]3, I. REQIN4, B. REQIN4, G.
BOGDANOVI]
5
, V. VIT. BALTI]
5
i Z. KERESZTES6
1
IHTM, Institut za elektrohemiju, Univerzitet u Beogradu, Wego{eva 12, Beograd,
2
Tehnolo{ko-metalur{ki
fakultet, Katedra za organsku hemiju, Karnegijeva 4, Univerzitet u Beogradu, Beograd,
3
Hemofarm Koncern,
Farmaceutsko-hemijska industrija, Vr{ac,
4
Elektrotehni~ki fakultet Univerziteta u Beogradu, Bulevar
Kraqa Aleksandra 73, Beograd,
5
Institut za onkologiju Sremska Kamenica, Institutski put 4, 21204 Sremska
Kamenica, Srbija i Crna Gora i
6
Chemical Research Center, Department of Nanostructures and Surface Modification, Budapest
1025, Pusztaszeri ut. 59-67, Hungary
DNA izolovana iz Erlihovih tumorskih }elija je AFM mikroskopijom posmatrana
prethodno tretirana adriamicinom i u netretiranom stawu, radi pore|ewa. AFM mikro-
skopija pru`a mogu}nost dobijawa direktne slike izgleda DNA strukture maligne }elije
koja nije tretirana lekom i iste strukture posle delovawa adrijamicina, {to daje nove
podatke o delovawu citostatika na malignu }eliju. Netretirane }elije (vi|ene AFM mikro-
skopijom) su ispoqile netaknutu strukturu hromatina koja odgovara intenzivnoj DNA
replikaciji u malignoj }eliji. Maligne }elije tretirane adriamicinom su pokazale da su
DNA lanci pokidani, tj. daqa replikacija je spre~ena, {to je jedan od osnova aktivnosti
citostatika. Multifraktalna analiza AFM mikroskopskih slika tretirane i netretirane
DNA je kvantitativno potvrdila zakqu~ke dobijene mikroskopijom jer su grafici AFM
slika uzoraka tretiranih adriamicinom pokazali fraktalniju strukturu od AFM slika
netretiranih malignih }elija kod kojih grafik ukazuje na potpuni gubitak fraktalnosti,
{to je znak prisutnog patolo{kog procesa u organizmu.
(Primqeno 6. avgusta, revidirano 12. oktobra 2004)
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